McDonald’s (MCD) is quietly scripting a new chapter in its long-running growth story—one that stretches from the South Loop of Chicago to the income statements of dividend-focused investors.
A Golden Arches Stadium Bet
In a move that marries sports, urban redevelopment, and…
Wall Street has seen plenty of turnarounds, but not many that involve lingerie, Big Macs and a Bioceramic pocket watch. Investors, however, seem happy to fund all three. Victoria’s Secret & Co. (NYSE: VSXY) is suddenly back in fashion with the market,…
McDonald’s (MCD) kicked off 2026 reminding investors that the Golden Arches are still a finely tuned cash machine, serving up earnings and revenue beats even as consumers count pennies and trade down on everything but fries.
McDonald’s Serves an Earnings Beat With…
McDonald’s (MCD) has handled low-carb fads, kale revolutions, and the brief reign of cauliflower rice, but its newest rival comes with a prescription label and a co-pay. GLP-1 weight-loss medicines—from injectables like Eli Lilly’s (LLY) Mounjaro and Zepbound to the next wave…
